Will acute gastroenteritis in babies cause myocarditis?

If there is a baby at home, parents have a great responsibility. They not only have to educate the baby well, but also protect the baby's health. Especially when the baby has abnormal physical condition, be sure to take him to the hospital for examination and treatment as soon as possible. So, for babies suffering from gastroenteritis, is it possible that myocarditis is caused by such a disease?

Some gastroenteritis is caused by viral infection, and myocarditis often occurs one month after gastroenteritis, so there is a certain relationship between the disease and the disease.

Myocarditis Treatment

The treatment of myocarditis is usually supportive therapy, especially for viral myocarditis (a self-limiting disease), which mainly focuses on the clinical manifestations of the disease.

Physical activity

Patients with acute myocarditis should avoid anaerobic exercise. A mouse model of Coxsackie B3 virus myocarditis showed that sustained high-intensity exercise increased mortality and suppressed T lymphocyte activity. Myocarditis is one of the causes of sudden death in young athletes. The 36th Bethesda Conference in 2005 pointed out that athletes suspected of myocarditis need to stop all competitive sports for more than 6 months. People can participate in training and competitions when the left ventricular structure and function return to normal and there is no arrhythmia. It is recommended that patients with myocarditis and stable heart failure participate in appropriate physical exercise.

Treatment of heart failure

It can be divided into two aspects: drug and (or) mechanical assisted treatment. According to the current drug treatment plan for heart failure, the following drugs should be selected based on the NYHA functional classification: beta-blockers, diuretics, ACEI, ARB, etc. For some patients whose condition continues to worsen despite optimal drug treatment, mechanical circulatory support or extracorporeal membrane oxygenation (ECMO) therapy can provide a bridge to recovery or heart transplantation. Even if the patient has an acute onset or is accompanied by severe clinical manifestations, he or she still has a good prognosis through active standardized treatment, with a survival rate of 60% to 80% and cardiac function returning to normal.

Treatment of heart rhythm disorders

The treatment of arrhythmia includes three aspects: etiology treatment, drug treatment and non-drug treatment. For patients who have no subjective symptoms and whose ventricular arrhythmias occur infrequently, myocarditis should be treated actively and antiarrhythmic drugs may not be used for the time being. According to the 2006 guidelines issued by the ACC/AHA and ESC, symptomatic or persistent arrhythmias should be treated. Symptomatic or persistent ventricular arrhythmias should be treated aggressively, using amiodarone if necessary. When patients with myocarditis develop severe atrioventricular block, glucocorticoids and isoproterenol can be used to increase the ventricular rate. If Ass syndrome occurs, a pacemaker needs to be implanted to help the patient through the acute phase. In 2013, the ESC recommended not to consider implanting an implantable cardioverter-defibrillator (ICD) during the acute phase, but to follow the ESC guidelines for the treatment of arrhythmias after the acute phase.